UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 29, 2024
(Exact name of registrant as specified in its charter)
|
Israel
|
001-36612
|
Not applicable
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
|
3 Hatnufa St., Floor 6, Yokneam Ilit, Israel
|
|
2069203
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: +972.4.959.0123
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instruction A.2. below):
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Ordinary Shares, par value NIS 0.25
|
|
LFWD
|
|
NASDAQ
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On January 29, 2024, ReWalk Robotics Ltd. issued a press release announcing that it will begin doing business as Lifeward™, effective on
January 29, 2024, and its Ordinary Shares will begin trading on The Nasdaq Capital Market under the new ticker symbol “LFWD” prior to market open on January 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No.
|
|
Document
|
|
|
|
|
|
104
|
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
* Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
|
ReWalk Robotics Ltd.
|
|
|
By:
|
/s/ Michael Lawless
|
|
|
Name:
|
Michael Lawless
|
|
|
Title:
|
Chief Financial Officer
|
Exhibit 99.1
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower
the pursuit of life’s ambitions in the face of physical limitation or disability.
The complete rebrand includes new name, stock ticker, logo, website launch, and corporate messaging.
MARLBOROUGH, MA, BERLIN, Germany, and YOKNEAM ILLIT, Israel,
(January 29, 2024) - ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”) today unveiled its new corporate branding to officially begin doing business as Lifeward™ (“Lifeward” or
the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability.
“With the recent addition of innovative solutions like the AlterG Anti-Gravity systems to our portfolio, we have surpassed the vision of
our original name,” said Larry Jasinski, CEO of Lifeward. “The transformation of ReWalk Robotics into Lifeward speaks to the broader goal of the Company to be the driving force to elevate the standard of care in overcoming physical limitations and
disabilities to empower individuals to do what they love.”
“Under the Lifeward brand, our newly combined commercial team will represent our full portfolio of solutions as a unified entity,” added
Charles Remsberg, Chief Sales Officer at Lifeward. “We believe this will allow us to drive growth for our business through better support of our customers across the rehabilitation spectrum. We have a portfolio of innovative solutions designed to
assist individuals in achieving their goals through improved functional and health outcomes – in the clinic as well as in the community.”
Starting today, the Company will begin doing business as
Lifeward. Additionally, beginning January 30, 2024, the Company’s ordinary shares will begin trading under the new Nasdaq stock ticker: LFWD. The new corporate website is available at GoLifeward.com and showcases the full portfolio of life-changing solutions, including the ReWalk Personal Exoskeleton, the
AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES systems.
To learn more about the new Lifeward identity and mission,
please visit GoLifeward.com.
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering
proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to
change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk
Exoskeleton, the AlterG Anti-Gravity systems, the ReStore Exo-Suit, and the MyoCycle FES Systems.
Founded in 2001, Lifeward has operations in the United
States, Israel, and Germany. For more information on the Lifeward portfolio, please visit GoLifeward.com.
ReWalk®, ReStore®, and Alter G® are registered trademarks of ReWalk Robotics Ltd. (DBA Lifeward) and/or its affiliates.
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act
of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may include projections regarding Lifeward's future performance and future
regulatory interactions and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to
uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Lifeward’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements are more fully discussed in the Company’s periodic
filings with the Securities and Exchange Commission (“SEC”), including the risk factors described under the heading "Risk Factors" in the Company’s annual report on Form 10-K and 10-K/A for the year ended December 31, 2022 filed with the SEC and
other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the
statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any forward-looking statements, whether as a
result of new information, future developments or otherwise.
Lifeward Media Relations:
LifeSci Communications
E: media@golifeward.com
Lifeward Investor Contact:
Mike Lawless
Chief Financial Officer
Lifeward
E: ir@golifeward.com